Bafrekalant
Bafrekalant is a diazabicyclo-substituted imidazo[1,2-a]pyrimidine derivative. It is a research compound used in the study of sleep-related breathing disorders, including obstructive and central sleep apnoea, facilitating both in vitro receptor binding assays and in vivo animal model experiments.
Product Specifications
CAS Number
2256770-44-0
Purity
99.87% (May vary between batches)
Solubility
DMSO:225 mg/mL (423.69 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.42 mM)
Smiles
COc1ccc (Cl) c (n1) C (=O) N1C2CCC1CN (Cc1c (nc3ncccn13) -c1ccc (cc1) C (C) C) C2
Molecular Formula
C29H31ClN6O2
Molecular Weight
531.05
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1483702-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details MBS1483702-02 0.02 mg (Yeast)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details MBS1483702-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details MBS1483702-04 0.1 mg (Yeast)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details MBS1483702-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details MBS1483702-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O6:K15:H31 HTH-type transcriptional activator rhaR (rhaR)
Sign In for Pricing
View Details